Cell Line Development Market Quadruples by 2022; with a ~ 11.44 % of Whooping CAGR | Lonza Group AG, Selexis SA, Sartorius AG, Thermo Fisher Scientific Inc., GE Healthcare, American Type Culture Collection (ATCC), European Collection of Cell Cultures (ECA

Cell Line Development Industry Trend Analysis:

In 2012, the Global Cell Line Development Market was evaluated approximately USD 1.92 billion and is anticipated to reach around USD 6.41 billion while maintaining a compound annual growth rate (CAGR) of 11.44% during the forecast period owing to rising demand for effective therapeutics, technological advancements, and monoclonal antibodies in cancer treatment field. The patent ending of megahit drugs like Abilify, Lantus, Androgel, and Namenda are anticipated to encourage the admission of new biosimilars. In recent period averagely, approximately 15 fresh proteins counting recombinant and therapeutic are being permitted by the United States Food and Drug Administration (FDA) yearly. Hence, elevated demand for innovative vaccines, drugs, therapeutic proteins, and biosimilars is anticipated to fuel the expansion of the cell line development market during the forecast years. Additionally, rising vaccine manufacturing, rising healthcare spending levels, acceptance of regenerative drugs and increase in funding concerning to research and development in the biotechnology market are some of the factors likely to drive future growth of the global market.

Cell Line Development - Competitive Outlook and Trend Analysis:

The key industry participants in the global cell line development market include Lonza Group AG, Selexis SA, Sartorius AG, Thermo Fisher Scientific Inc., GE Healthcare, American Type Culture Collection (ATCC), European Collection of Cell Cultures (ECACC), Corning Inc., Sigma-Aldrich Corporation, and WuXi AppTec Inc. The global market is characteristically competitive noticed by high market rivalries. Market players are determined to achieve competitive benefit by exploring the available unused opportunities.

Access sample copy of this report: https://www.crystalmarketresearch.com/report-sample/HC10280 .

Cell Line Development - Cell Line Development - Application Outlook and Trend Analysis:

The applications segment includes the production of monoclonal antibodies, vaccines, research, and bioproduction; tissue engineering; and drug discovery toxicity testing. The products have key application in bioproduction including therapeutic proteins, vaccines, and other biologics production. Additionally, an increase in research and development activities, the advent of biosimilars as well as accessibility of technologically superior procedures for large-scale manufacturing of biologics is anticipated to boost the expansion of this application section in future.

Cell Line Development - Type Outlook and Trend Analysis:

Depending on the type, the market is classified into recombinant, hybridomas, primary, and continuous. Since 2014, recombinant was the major revenue rendering section owing to its superior pertinence in biologics production, protein interactions and gene activation above traditional cell assay methods. Moreover, increasing demand for toxicity testing and drug screening are anticipated to boost growth for the segment. Hybridomas sectional growth is anticipated to be in synchronization with the recombinant section largely due to the ability of large-scale incessant antibody production.

Cell Line Development - Product Outlook and Trend Analysis:

In 2014, reagents and media ruled the global market concerning revenue. Rising bioproduction demanding reagents and media, right from incubation until line preservation and price exhaustive nature are the driving factors during the forecast years. Reagents utilized are attachments and matrix factors, antibiotics, freezing and dissociation reagents, miscellaneous reagents, biological buffers, and cell separation. Nutrients which are necessary for proper growth of the growing cells, Salts, and media are active in rendering that. MEM media, DMEM media, RPMI media, medium 199, Hans F-10 media, and other classical ones are frequently utilized media in cell growth.

The Global Cell Line Development Market is segmented as follows –

Cell Line Development - By Product:

Equipment
Accessories and Consumables
Reagents and Media
Centrifuges
Incubators
Storage Equipment
Bioreactors
Microscopes

Cell Line Development - By Application:

Bioproduction
Toxicity Testing
Drug Discovery
Research
Tissue Engineering

Cell Line Development - By Type of Cell Lines:

Continuous Cell Lines
Recombinant Cell Lines
Primary Cell Lines
Hybridomas

Cell Line Development - By Source:

Non Mammalian Cell Line
Amphibians
Insects
Mammalian Cell Line

In order to browse complete report with TOC: https://www.crystalmarketresearch.com/report/cell-line-development-market .

Cell Line Development - Source Outlook and Trend Analysis:

In 2014, the mammalian source for product improvement ruled the global demand owing to rising implementation rates for the monoclonal antibodies production and its capability to articulate complex proteins like human beings. Additionally, improved expression systems, as well as technology for mammalian cell source expansion, are anticipated to boost the industry growth. There are around 4,000 mammalian lines existing and research is going on for the advent of few more.

Cell Line Development - By Region:

North America - U.S, Canada, Mexico

Europe - Germany, France, UK, Italy, Spain, Rest of Europe

Asia-Pacific - Japan, China, Australia, India, South Korea, Rest of Asia Pacific

Rest of the World - Brazil, South Africa, Saudi Arabia, United Arab Emirates, Others

Cell Line Development - Regional Outlook and Trend Analysis:

In 2014, North American cell line development regional market was the leading with revenues of around USD 800 million. The existence of advanced medical infrastructure, encouraging government initiatives concerning to development of the product, and growing awareness regarding the curative application of monoclonal antibodies in the treatment of cancer are a few major driving factors. Asia Pacific regional market is projected to experience productive CAGR during the forecast period owing to the existence of high unused opportunities along with speedily rising awareness among patients about effective treatments for cancer as well as increasing trend of research outsourcing from developing countries like China and India.

Cell Line Development - List of Tables:

Table 1.Global Cell Line Development Market, By Product, 2012-2022 ($Million)
Table 2.Reagents and Media Market, By Region, 2012-2022 ($Million)
Table 3.Accessories and Consumables Market, By Region, 2012-2022 ($Million)
Table 4.Equipment Market, By Type, 2012-2022 ($Million)
Table 5.Equipment Market, By Region, 2012-2022 ($Million)
Table 6.Centrifuges Market, By Region, 2012-2022 ($Million)
...

Cell Line Development - List of Figures:

Figure 1.Cell Line Development Market Share, By Product, 2012 & 2022 ($Million)
Figure 2.Cell Line Development Market Share, By Application, 2012 & 2022 ($Million)
Figure 3.Cell Line Development Market Share, By Type of Cell Lines, 2012 & 2022 ($Million)
Figure 4.Cell Line Development Market Share, By Source, 2012 & 2022 ($Million)
Figure 5.Cell Line Development Market, By Region, 2012 & 2022, ($Million)
Figure 6.GE Healthcare: Net Revenues, 2014-2016 ($Million)
...

Key findings of the Cell Line Development Market -

• In 2014, reagent and media was the leading product market, due to rising number of cell culture processes.

• In 2014, mammalian cell lines were extensively utilized as cell line development source, due to linked advantages like vital manufacturing of monoclonal vaccines, biologics, and antibodies and correct complex protein expression nature.

• Cell line development has the major application in the bioproduction of therapeutic proteins, biologics, mAbs, biosimilar and vaccines.

• In 2014, North American regional market was the largest one, with market revenue valued at around 800 million owing to the existence of well-developed medical infrastructure, rising cell culture techniques’ adoption rates, encouraging government initiatives and elevated medical expenditure levels.

Check best offer of this report: https://www.crystalmarketresearch.com/check-discount/HC10280 .

Continued…

About Crystal Market Research:

Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customised research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us:
Judy
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: sales@crystalmarketresearch.com

This release was published on openPR.